US stock screener
Every US-listed company we cover. Most columns are company-reported figures from each company’s own SEC filings; P/E, market cap and dividend yield are market-derived, combining SEC share counts and TTM results with a stored price, last retrieved on a rolling basis and typically within the past week. Click a column to sort, or open a company for its full statements with per-figure provenance.
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | Healthcare | $45.6Mpit | $27.5M | -34.3% | -28.1% | -16.0% | — | — |
| Immucell Corp. (ICCC) | Healthcare | $94.8Mpit | $27.6M | 4.3% | -3.8% | -3.8% | — | — |
| American Shared Hospital Services (AMS) | Healthcare | $8.4Mpit | $28.1M | -0.9% | -5.5% | -5.6% | — | — |
| Bionano Genomics, Inc. (BNGO) | Healthcare | $14.7Mpit | $28.5M | -7.4% | -92.6% | -59.4% | — | — |
| CapForce Inc. (CFOR) | Healthcare | $50.0Mpit | $30.2M | 481.2% | 78.2% | 74.1% | 0.7 | — |
| Scilex Holding Co (SCLX) | Healthcare | $20.0Mpit | $30.3M | -46.5% | — | — | — | — |
| Synergy CHC Corp. (SNYRQ) | Healthcare | $119,199pit | $30.4M | -12.8% | -40.6% | — | — | — |
| STRATA Skin Sciences, Inc. (SSKN) | Healthcare | $1,177vendor | $30.7M | -8.5% | -20.4% | -215.3% | — | — |
| Foghorn Therapeutics Inc. (FHTX) | Healthcare | $119.4Mpit | $30.9M | 36.8% | — | — | — | — |
| Verastem, Inc. (VSTM) | Healthcare | $783.4Mpit | $30.9M | 209.1% | — | -366.2% | — | — |
| EyePoint, Inc. (EYPT) | Healthcare | $36.9Mpit | $31.4M | -27.5% | — | -75.8% | — | — |
| Precision Optics Corporation, Inc. (POCI) | Healthcare | $47.5Mpit | $31.5M | 65.2% | -11.5% | -17.8% | — | — |
| Cryo Cell International Inc. (CCEL) | Healthcare | $37.7Mpit | $31.6M | -1.3% | -7.7% | — | — | 0.0% |
| Sonendo, Inc. (SONX) | Healthcare | $6.1Mvendor | $31.7M | -8.4% | -88.4% | -540.0% | — | — |
| Premier Air Charter Holdings Inc. (PREM) | Healthcare | $5.6Mpit | $31.9M | 53.6% | -12.1% | -97.4% | — | — |
| Zomedica Corp. (ZOMDF) | Healthcare | $77.4Mpit | $32.0M | 17.4% | — | -70.9% | — | — |
| electroCore, Inc. (ECOR) | Healthcare | $66.8Mpit | $32.0M | 27.2% | -43.6% | — | — | — |
| Stereotaxis, Inc. (STXS) | Healthcare | $101.2Mpit | $32.4M | 20.3% | -66.8% | — | — | 0.0% |
| C21 Investments Inc. (CWLXF) | Healthcare | $31.4Mvendor | $32.6M | 8.3% | -9.9% | -12.8% | — | — |
| Maxcyte, Inc. (MXCT) | Healthcare | $144.5Mpit | $33.0M | -14.5% | — | -26.0% | — | — |
| Orchestra BioMed Holdings, Inc. (OBIO) | Healthcare | $336.0Mpit | $33.5M | 1169.2% | — | — | — | — |
| Rapid Micro Biosystems, Inc. (RPID) | Healthcare | $38.7Mpit | $33.6M | 19.7% | — | -141.9% | — | — |
| Precision Biosciences Inc. (DTIL) | Healthcare | $187.1Mpit | $34.3M | -50.1% | — | -49.6% | — | — |
| Bioharvest Sciences Inc. (BHST) | Healthcare | $37.9Mvendor | $34.5M | 37.0% | -32.3% | -43.8% | — | — |
| Leef Brands Inc. (LEEEF) | Healthcare | $45.8Mpit | $34.8M | 22.1% | -50.7% | — | — | — |
| X4 Pharmaceuticals, Inc (XFOR) | Healthcare | $256.8Mpit | $35.1M | 1273.2% | — | -42.5% | — | — |
| Verrica Pharmaceuticals Inc. (VRCA) | Healthcare | $61.8Mpit | $35.6M | 370.2% | -50.3% | -72.3% | — | — |
| Earth Science Tech, Inc. (ETST) | Healthcare | $25.9Mpit | $35.7M | 7.8% | 10.2% | 51.6% | 6.7 | — |
| C4 Therapeutics, Inc. (CCCC) | Healthcare | $390.0Mpit | $35.9M | 1.0% | — | -40.9% | — | — |
| Sunshine Biopharma Inc. (SBFM) | Healthcare | $3.3Mvendor | $36.3M | 4.1% | -16.5% | -25.9% | — | — |
| Lftd Partners Inc. (LIFD) | Healthcare | $1.5Mpit | $36.9M | -1.1% | -67.3% | -196.8% | — | — |
| ClearPoint Neuro, Inc. (CLPT) | Healthcare | $282.2Mpit | $37.0M | 17.8% | -69.1% | -91.1% | — | — |
| Cytosorbents Corp (CTSO) | Healthcare | $16.9Mvendor | $37.1M | 4.1% | -22.1% | -138.9% | — | — |
| BGM Group Ltd. (BGM) | Healthcare | $119.8Mvendor | $37.9M | 51.1% | -52.6% | -5.1% | — | — |
| Retractable Technologies Inc. (RVP) | Healthcare | $17.2Mpit | $38.3M | 15.8% | -32.8% | -16.9% | — | — |
| Utah Medical Products Inc. (UTMD) | Healthcare | $237.2Mpit | $38.5M | -5.8% | 29.3% | 9.5% | 22.7 | 1.7% |
| Interpace Biosciences, Inc. (IDXG) | Healthcare | $31.9Mvendor | $38.7M | -17.5% | 63.5% | 109.9% | — | — |
| Kymera Therapeutics, Inc. (KYMR) | Healthcare | $9.22Bpit | $39.2M | -16.7% | — | -19.7% | — | — |
| Sangamo Therapeutics, Inc. (SGMOQ) | Healthcare | $49.7Mpit | $39.6M | -31.6% | — | — | — | — |
| Voyager Therapeutics, Inc. (VYGR) | Healthcare | $124.5Mpit | $40.4M | -49.5% | — | -61.1% | — | — |
| Editas Medicine, Inc. (EDIT) | Healthcare | $382.4Mpit | $40.5M | 25.4% | — | -586.6% | — | — |
| Alpha Teknova, Inc. (TKNO) | Healthcare | $380.1Mpit | $40.5M | 7.4% | -42.6% | -25.1% | — | — |
| Myomo, Inc. (MYO) | Healthcare | $47.9Mpit | $40.9M | 25.7% | -38.1% | -136.6% | — | — |
| KORU Medical Systems, Inc. (KRMD) | Healthcare | $146.4Mpit | $41.1M | 22.2% | -6.4% | -15.5% | — | — |
| Biofrontera Inc. (BFRI) | Healthcare | $11.9Mpit | $41.7M | 11.7% | -25.3% | -100.5% | — | — |
| Coherus Oncology, Inc. (CHRS) | Healthcare | $157.6Mpit | $42.2M | 59.8% | — | 275.4% | — | — |
| SS Innovations International, Inc. (SSII) | Healthcare | $507.0Mpit | $42.5M | 105.7% | -28.5% | -31.7% | — | — |
| Wave Life Sciences, Inc. (WVE) | Healthcare | $626.6Mpit | $42.7M | -60.5% | — | -39.4% | — | — |
| Xilio Therapeutics, Inc. (XLO) | Healthcare | $56.3Mvendor | $43.8M | 589.9% | -80.1% | -99.3% | — | — |
| Integrated Biopharma Inc. (INBP) | Healthcare | $5.6Mpit | $43.9M | -19.3% | -6.5% | -16.1% | — | — |
| SANUWAVE Health, Inc. (SNWV) | Healthcare | $42.7Mpit | $44.1M | 36.3% | 26.8% | 729.6% | — | — |
| Cumberland Pharmaceuticals Inc. (CPIX) | Healthcare | $122.4Mpit | $44.5M | 17.6% | -6.4% | -11.6% | — | — |
| Aquestive Therapeutics, Inc. (AQST) | Healthcare | $480.7Mpit | $44.5M | -22.6% | — | — | — | — |
| Fennec Pharmaceuticals Inc. (FENC) | Healthcare | $361.9Mpit | $44.6M | -6.1% | -21.8% | -27.5% | — | — |
| TriSalus Life Sciences, Inc. (TLSI) | Healthcare | $223.5Mpit | $45.2M | 53.4% | -86.9% | — | — | — |
| Septerna, Inc. (SEPN) | Healthcare | $1.70Bpit | $46.0M | 4174.5% | — | -12.8% | — | — |
| Protagonist Therapeutics, Inc (PTGX) | Healthcare | $8.70Bpit | $46.0M | -89.4% | — | -21.2% | — | — |
| Shoulder Innovations, Inc. (SI) | Healthcare | $376.6Mpit | $47.3M | 49.6% | -85.3% | -28.7% | — | — |
| Gossamer Bio, Inc. (GOSS) | Healthcare | $57.9Mvendor | $48.5M | -57.7% | — | — | — | — |
| Lexicon Pharmaceuticals, Inc. (LXRX) | Healthcare | $631.8Mpit | $49.8M | 729.9% | — | -46.8% | — | — |
| Carlsmed, Inc. (CARL) | Healthcare | $390.7Mpit | $50.5M | 85.9% | -58.7% | -30.0% | — | — |
| LENSAR, Inc. (LNSR) | Healthcare | $74.6Mpit | $51.7M | 12.4% | -66.4% | — | — | — |
| Ocular Therapeutix, Inc. (OCUL) | Healthcare | $1.45Bpit | $52.0M | -18.5% | — | -40.6% | — | — |
| XOMA Royalty Corp (XOMA) | Healthcare | $710.2Mvendor | $52.1M | 83.1% | 60.8% | — | — | — |
| Iridex Corp. (IRIX) | Healthcare | $13.4Mpit | $52.7M | 8.2% | -8.4% | -90.1% | — | — |
| Protalix BioTherapeutics, Inc. (PLX) | Healthcare | $205.5Mpit | $52.7M | -1.2% | -12.5% | -13.7% | — | — |
| Apyx Medical Corp (APYX) | Healthcare | $101.9Mpit | $52.8M | 9.9% | -21.2% | -75.6% | — | — |
| Invivyd, Inc. (IVVD) | Healthcare | $179.8Mpit | $53.4M | 110.5% | -98.2% | -21.7% | — | — |
| Q32 Bio Inc. (QTTB) | Healthcare | $257.5Mpit | $53.7M | — | 55.5% | 71.0% | 2.9 | — |
| Agios Pharmaceuticals, Inc. (AGIO) | Healthcare | $2.22Bpit | $54.0M | 48.0% | — | -34.6% | — | — |
| Nektar Therapeutics (NKTR) | Healthcare | $1.32Bpit | $55.2M | -43.9% | — | -182.6% | — | — |
| 908 Devices Inc. (MASS) | Healthcare | $474.9Mpit | $56.2M | 17.7% | 34.7% | 13.6% | — | — |
| CVRx, Inc. (CVRX) | Healthcare | $36.5Mpit | $56.7M | 10.4% | -94.1% | -135.6% | — | — |
| Aytu Biopharma, Inc. (AYTU) | Healthcare | $21.3Mpit | $57.6M | -13.3% | -24.8% | -40.4% | — | — |
| Alpha Pro Tech Ltd. (APT) | Healthcare | $56.6Mpit | $59.1M | 2.3% | 6.0% | 5.7% | 13.6 | — |
| Champions Oncology, Inc. (CSBR) | Healthcare | $67.5Mpit | $59.4M | 4.4% | -2.0% | -28.9% | — | — |
| Journey Medical Corp (DERM) | Healthcare | $147.3Mpit | $61.2M | 11.1% | -18.7% | -35.9% | — | — |
| Fortress Biotech, Inc. (FBIO) | Healthcare | $64.7Mvendor | $61.2M | 11.1% | 11.1% | 11.0% | — | — |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | Healthcare | $5.6Mvendor | $61.8M | -36.2% | 11.0% | 3.6% | — | — |
| Tango Therapeutics, Inc. (TNGX) | Healthcare | $3.72Bpit | $62.4M | 48.3% | — | -29.3% | — | — |
| Nuvation Bio Inc. (NUVB) | Healthcare | $1.60Bpit | $62.9M | 699.0% | — | -66.9% | — | — |
| Concord Medical Services Holdings Ltd (CCM) | Healthcare | $16.0Mvendor | $65.0M | 26.6% | -20.4% | -5.0% | — | — |
| Cosmos Health Inc. (COSM) | Healthcare | $28.2Mpit | $65.3M | 19.9% | -29.3% | -103.9% | — | — |
| Enanta Pharmaceuticals Inc. (ENTA) | Healthcare | $338.4Mpit | $65.3M | -3.4% | — | -126.5% | — | — |
| Exagen Inc. (XGN) | Healthcare | $176.1Mpit | $66.6M | 19.7% | -30.0% | -114.3% | — | — |
| Spero Therapeutics, Inc. (SPRO) | Healthcare | $64.6Mpit | $66.8M | 39.2% | 12.8% | 14.5% | 27.3 | — |
| Kura Oncology, Inc. (KURA) | Healthcare | $877.2Mpit | $67.5M | 25.2% | — | -160.0% | — | — |
| Intellia Therapeutics, Inc. (NTLA) | Healthcare | $1.56Bpit | $67.7M | 16.9% | — | -61.5% | — | — |
| Vir Biotechnology, Inc. (VIR) | Healthcare | $1.79Bpit | $68.6M | -7.6% | — | -57.2% | — | — |
| Rockwell Medical, Inc. (RMTI) | Healthcare | $28.0Mpit | $69.3M | -31.8% | -7.7% | -14.4% | — | — |
| Personalis, Inc. (PSNL) | Healthcare | $1.69Bpit | $69.6M | -17.7% | — | -31.1% | — | — |
| Black Diamond Therapeutics, Inc. (BDTX) | Healthcare | $119.5Mpit | $70.0M | — | 32.0% | 19.9% | — | — |
| Edap Tms SA (FOCL) | Healthcare | $155.7Mpit | $70.5M | 1.6% | -41.5% | -150.7% | — | — |
| Viridian Therapeutics, Inc.\DE (VRDN) | Healthcare | $2.53Bpit | $70.8M | 23359.9% | — | -47.4% | — | — |
| AVITA Medical, Inc. (RCEL) | Healthcare | $479.7Mpit | $70.9M | 10.9% | -68.5% | — | — | — |
| Assembly Biosciences, Inc. (ASMB) | Healthcare | $410.5Mpit | $72.3M | 153.5% | -8.5% | -3.0% | — | — |
| Bicycle Therapeutics PLC (BCYC) | Healthcare | $249.9Mpit | $72.6M | 105.8% | — | -35.9% | — | — |
| Compugen Ltd. (CGEN) | Healthcare | $200.8Mvendor | $72.8M | 161.1% | 48.6% | 34.4% | — | — |
| Electromed, Inc. (ELMD) | Healthcare | $224.8Mpit | $73.8M | 15.3% | 15.3% | 20.9% | 20.5 | — |
| Recursion Pharmaceuticals, Inc. (RXRX) | Healthcare | $1.96Bpit | $74.7M | 26.9% | — | -57.0% | — | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR, as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.